Scott Beach

Scott Beach, M.D., a leading expert in pharmacology, dives into a significant 23-year study examining the interplay between SSRIs and oral anticoagulants. He discusses the startling 33% increased risk of major bleeding events observed in patients with atrial fibrillation using both treatments. The conversation also highlights critical strategies for safe prescribing and monitoring, particularly during the initial treatment phase. Beach emphasizes the need for personalized approaches to mitigate risks, including potential medication adjustments and diligent oversight.